ASCO: Non-Small Cell Lung Cancer
<ѻý class="page-description">American Society of Clinical Oncologyѻý>More in ASCO: Non-Small Cell Lung Cancer
The immune-related adverse event is rare and manageable, but not necessarily reversible
Jun 25, 2021
The immune-related adverse event is rare and manageable, but not necessarily reversible